These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18980202)

  • 1. Toward using National Cancer Surveillance data for preventing and controlling cervical and other human papillomavirus-associated cancers in the US.
    Saraiya M; Ahmed F; White M; Lawson H; Unger ER; Eheman C
    Cancer; 2008 Nov; 113(10 Suppl):2837-40. PubMed ID: 18980202
    [No Abstract]   [Full Text] [Related]  

  • 2. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
    Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
    Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point.
    Giuliano AR; Salmon D
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):805-8. PubMed ID: 18398020
    [No Abstract]   [Full Text] [Related]  

  • 5. StatBite: Proportion of specific cancers caused by HPV.
    J Natl Cancer Inst; 2010 Jun; 102(12):839. PubMed ID: 20530763
    [No Abstract]   [Full Text] [Related]  

  • 6. [Papillomavirus, could we speak about cancer and prevention?].
    Pernot S; Pavie J; Péré H; Menard M; Hurel S; Cochand-Priollet B; Bats AS; Badoual C
    Bull Cancer; 2018 Feb; 105(2):137-139. PubMed ID: 29373106
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conclusions about human papillomavirus-related malignancies.
    Yarbrough WG; Rosenthal E
    Head Neck; 2014 Jun; 36(6):826-7. PubMed ID: 23696473
    [No Abstract]   [Full Text] [Related]  

  • 9. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
    Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
    Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden and trends of type-specific human papillomavirus infections and related diseases in the Asia Pacific region.
    Parkin DM; Louie KS; Clifford G
    Vaccine; 2008 Aug; 26 Suppl 12():M1-16. PubMed ID: 18945410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The case for HPV immunization.
    Campos-Outcalt D
    J Fam Pract; 2009 Dec; 58(12):660-4. PubMed ID: 19961821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradicating HPV-Associated Cancer Through Immunization: A Glass Half Full….
    Frazer IH
    Viral Immunol; 2018 Mar; 31(2):80-85. PubMed ID: 29298130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. For cancers caused by HPV, two vaccines were just the beginning.
    Peres J
    J Natl Cancer Inst; 2011 Mar; 103(5):360-2. PubMed ID: 21357595
    [No Abstract]   [Full Text] [Related]  

  • 14. Human Papillomavirus-Attributable Cancers - United States, 2012-2016.
    Senkomago V; Henley SJ; Thomas CC; Mix JM; Markowitz LE; Saraiya M
    MMWR Morb Mortal Wkly Rep; 2019 Aug; 68(33):724-728. PubMed ID: 31437140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global prevention and management of human papillomavirus related diseases: the pressing challenges and the compelling opportunities. Foreword.
    Broker TR
    Vaccine; 2012 Nov; 30 Suppl 5():vii-x. PubMed ID: 23199970
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary and secondary prevention of cervical cancer--opportunities and challenges.
    Markowitz LE; Unger ER; Saraiya M
    J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638
    [No Abstract]   [Full Text] [Related]  

  • 17. HPV-related cancers after solid organ transplantation in the United States.
    Madeleine MM; Finch JL; Lynch CF; Goodman MT; Engels EA
    Am J Transplant; 2013 Dec; 13(12):3202-9. PubMed ID: 24119294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-level incidence of human papillomavirus-positive oropharyngeal, cervical, and anal cancers, by smoking status.
    Gopalani SV; Saraiya M; Huang B; Tucker TC; Mix JM; Chaturvedi AK
    J Natl Cancer Inst; 2024 Jul; 116(7):1173-1177. PubMed ID: 38429996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.
    Rose Ragin CC; Taioli E
    Head Neck; 2008 Jan; 30(1):58-66. PubMed ID: 17657793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Sep; 105(18):1335-6. PubMed ID: 23990671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.